Literature DB >> 10913193

Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability.

J J Derry1, S Richard, H Valderrama Carvajal, X Ye, V Vasioukhin, A W Cochrane, T Chen, A L Tyner.   

Abstract

Sik (mouse Src-related intestinal kinase) and its orthologue BRK (human breast tumor kinase) are intracellular tyrosine kinases that are distantly related to the Src family and have a similar structure, but they lack the myristoylation signal. Here we demonstrate that Sik and BRK associate with the RNA binding protein Sam68 (Src associated during mitosis, 68 kDa). We found that Sik interacts with Sam68 through its SH3 and SH2 domains and that the proline-rich P3 region of Sam68 is required for Sik and BRK SH3 binding. In the transformed HT29 adenocarcinoma cell cell line, endogenous BRK and Sam68 colocalize in Sam68-SLM nuclear bodies (SNBs), while transfected Sik and Sam68 are localized diffusely in the nucleoplasm of nontransformed NMuMG mammary epithelial cells. Transfected Sik phosphorylates Sam68 in SNBs in HT29 cells and in the nucleoplasm of NMuMG cells. In functional studies, expression of Sik abolished the ability of Sam68 to bind RNA and act as a cellular Rev homologue. While Sam68 is a substrate for Src family kinases during mitosis, Sik/BRK is the first identified tyrosine kinase that can phosphorylate Sam68 and regulate its activity within the nucleus, where it resides during most of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913193      PMCID: PMC86087          DOI: 10.1128/MCB.20.16.6114-6126.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines.

Authors:  T Chen; F M Boisvert; D P Bazett-Jones; S Richard
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62.

Authors:  G Wong; O Müller; R Clark; L Conroy; M F Moran; P Polakis; F McCormick
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

3.  SH2 domains recognize specific phosphopeptide sequences.

Authors:  Z Songyang; S E Shoelson; M Chaudhuri; G Gish; T Pawson; W G Haser; F King; T Roberts; S Ratnofsky; R J Lechleider
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

Review 4.  The when and how of Src regulation.

Authors:  J A Cooper; B Howell
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

5.  The KH domain occurs in a diverse set of RNA-binding proteins that include the antiterminator NusA and is probably involved in binding to nucleic acid.

Authors:  T J Gibson; J D Thompson; J Heringa
Journal:  FEBS Lett       Date:  1993-06-21       Impact factor: 4.124

6.  Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.

Authors:  T J Hope; X J Huang; D McDonald; T G Parslow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  A point mutation in the FMR-1 gene associated with fragile X mental retardation.

Authors:  K De Boulle; A J Verkerk; E Reyniers; L Vits; J Hendrickx; B Van Roy; F Van den Bos; E de Graaff; B A Oostra; P J Willems
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

8.  The pre-mRNA binding K protein contains a novel evolutionarily conserved motif.

Authors:  H Siomi; M J Matunis; W M Michael; G Dreyfuss
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

9.  Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

Authors:  K L Guan; J E Dixon
Journal:  Anal Biochem       Date:  1991-02-01       Impact factor: 3.365

10.  New acceptor cell for transfected genomic DNA: oncogene transfer into a mouse mammary epithelial cell line.

Authors:  N E Hynes; R Jaggi; S C Kozma; R Ball; D Muellener; N T Wetherall; B W Davis; B Groner
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

View more
  58 in total

1.  Sam68 enhances the cytoplasmic utilization of intron-containing RNA and is functionally regulated by the nuclear kinase Sik/BRK.

Authors:  John H Coyle; Brian W Guzik; Yeou-Cherng Bor; Li Jin; Lucia Eisner-Smerage; Stephen J Taylor; David Rekosh; Marie-Louise Hammarskjöld
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

2.  Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.

Authors:  Osamu Ikeda; Yuichi Sekine; Akihiro Mizushima; Misa Nakasuji; Yuto Miyasaka; Chikako Yamamoto; Ryuta Muromoto; Asuka Nanbo; Kenji Oritani; Akihiko Yoshimura; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

Review 3.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

4.  Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.

Authors:  Maria Paola Paronetto; Manuela Cappellari; Roberta Busà; Simona Pedrotti; Roberta Vitali; Clay Comstock; Terry Hyslop; Karen E Knudsen; Claudio Sette
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

5.  Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.

Authors:  Monika Kasprzycka; Miroslaw Majewski; Zhi-Jong Wang; Andrzej Ptasznik; Maria Wysocka; Qian Zhang; Michal Marzec; Phyllis Gimotty; Mark R Crompton; Mariusz A Wasik
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

6.  Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.

Authors:  Hsin-Yi Chen; Che-Hung Shen; Yuh-Tyng Tsai; Feng-Chi Lin; Yuan-Ping Huang; Ruey-Hwa Chen
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 7.  Targeting protein tyrosine kinase 6 in cancer.

Authors:  Milica B Gilic; Angela L Tyner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-09-18       Impact factor: 10.680

8.  Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.

Authors:  Nancy E Castro; Carol A Lange
Journal:  Breast Cancer Res       Date:  2010-08-05       Impact factor: 6.466

9.  The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.

Authors:  Patrick M Brauer; Yu Zheng; Mark D Evans; Carmen Dominguez-Brauer; Donna M Peehl; Angela L Tyner
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

10.  Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies.

Authors:  Prabhakar Rajan; Caroline Dalgliesh; Cyril F Bourgeois; Monika Heiner; Kaveh Emami; Emma L Clark; Albrecht Bindereif; James Stevenin; Craig N Robson; Hing Y Leung; David J Elliott
Journal:  BMC Cell Biol       Date:  2009-11-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.